tirzepatide and macular degeneration Study finds association between GLP-1 use in diabetes is tirzepatide safe long term

Ferreira JP, Neves JS (2022) Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind

Key dangers include: Overdose or underdose: Errors in calculation can result in receiving far more or far less than the intended amount, leading to severe adverse effects or no therapeutic benefit Microbial contamination: Without pharmaceutical-grade manufacturing conditions, vials may be contaminated with bacteria or fungi, risking serious infection including sepsis Chemical degradation: Improper storage, incorrect diluent, or excessive agitation can degrade the peptide, producing unknown breakdown products Injection site complications: Subcutaneous injections performed without training can cause lipodystrophy, abscess formation, or nerve injury There is also a psychological dimension to consider

Cyanocobalamin injections usually have 1000 mcg/ml of vitamin B12

Not an indication of safety or efficacy